Peder Seglund

Peder Seglund, Ph.D. has a diverse and extensive work experience. Peder is currently working at Indegene as the Vice-President of Global Business Development. Prior to this, they worked at Qinecsa Solutions as the Chief Commercial Officer, where they provided end-to-end pharmacovigilance services, solutions, and technology for pharmaceutical, biotech, and medical device companies. Before that, they served as the Vice-President of Global Business Development at Dr. Evidence, where they led medical intelligence platforms for life science companies. Peder Seglund also worked at Navitas Life Sciences as a Global Client Partner in Business Development and at CROS NT as the Senior Vice-President of Commercial in North America. Peder has experience as the Chief Commercial Officer and Head of Neuroscience at Synaptech Microdialysis and CRO, where they managed a global client list and built strategic relationships. Additionally, they served as the Chief Commercial Officer at PGXL Laboratories, where they launched a national genetics sales campaign and managed various aspects of the business development cycle.

Peder Seglund, Ph.D., holds a Doctor of Philosophy (Ph.D.) degree in Organizational Behavior from Western Michigan University. Prior to their doctoral studies, they earned a Master of Science (MS) degree in Behavioral Neuroscience from Northern Michigan University. Peder also holds a Bachelor of Science (B.S.) degree in Business, Management, Marketing, and Related Support Services, also from Northern Michigan University.